Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference76 articles.
1. Renfro LA, An M-W, Mandrekar SJ. Precision oncology: a new era of cancer clinical trials. Cancer Lett. 2017;387:121–6.
2. Ivanova A, Paul B, Marchenko O, Song G, Patel N, Moschos SJ. Nine-year change in statistical design, profile, and success rates of phase II oncology trials. J Biopharm Stat. 2016;26(1):141–9.
3. Thezenas S, Duffour J, Culine S, Kramar A. Five-year change in statistical designs of phase II trials published in leading cancer journals. Eur J Cancer. 2004;40(8):1244–9.
4. FDA, Guidance Document: Adaptive designs for clinical trials of drugs and biologics, 2019.
5. Simon R. Designs for efficient clinical trials. Oncology. 1989;3(7):43–9.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献